With its name changed from Neogenis to HumanN in 2016, the firm describes its operation as anchored in research on Nitric Oxide that began with the discovery of its unique impact on cardiovascular health and as a biological signaling molecule. The latter work resulted in the awarding of the Nobel Prize in Nobel Prize in Physiology or Medicine for 1998 to Robert F. Furchgott, Louis J. Ignarro and Ferid Murad for their discoveries concerning "nitric oxide as a signalling molecule in the cardiovascular system". At the Texas Health Science Center, Neogenis Laboratories, now HumanN is working on development of products designed to replenish the bodys N-O, and even to help the body to promote optimal N-O function through a range of N-O functional foods and supplements
